B. Ashleigh Guadagnolo

Professor

MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

B. Ashleigh Guadagnolo is a Professor at MD Anderson Cancer Center, USA. Her research focuses on the role of radiotherapy and immunotherapy in treating various types of melanoma and soft tissue sarcomas. Recent publications include studies on neoadjuvant therapies, adjuvant radiation therapy, and the significance of plasma DNA methylation-based biomarkers for cancer detection.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

B. Ashleigh Guadagnolo

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Resectable Sinonasal Mucosal Melanoma in the Immunotherapy Era: Upfront Surgery vs. Neoadjuvant Therapy.

ASO Author Reflections: Neoadjuvant Hypofractionated Radiotherapy in Extremity Soft Tissue Sarcoma: Are There Devils in the Details?

The Landmark Series: Neoadjuvant Radiotherapy in Extremity Soft Tissue Sarcoma-The Way to Hypofractionation.

Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT‐STS): Updated local control, late toxicities, and patient‐reported outcomes

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma

Adjuvant Radiation Therapy in Desmoplastic Melanoma: A Scoping Review.

Nodal Radiotherapy for Anorectal Melanoma: Finding the Appropriate Time and Place.

Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1.

Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue Sarcoma.

Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.

Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results from the Lead-In Phase of the Randomized Basket Trial EXTEND.

Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention.

The Goldilocks Spot for Radiation Therapy in Anorectal Melanoma: Yes to the Primary Site After Local Excision; No to the Groin.

Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020.

Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials.

Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions.

Geographic Access to Radiation Therapy Facilities in the United States.

Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline

Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era

Collaborators (6)

Ahsan Farooqi

Scot Callahan

Andrew Bishop

Elise Nassif

Roi Weiser

Ramez Kouzy

Make your next move.